Clinical Trials Browser

Triple Negative Breast Neoplasms × Erlotinib Hydrochloride × Thoracic × Clear all

NCT05827614 2026-01-23

POTENTIATE

Squamous Cell Carcinoma of Head and Neck, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms